论文部分内容阅读
[目的]观察祛风解表药为主联合西药治疗急性期缺血性中风疗效。[方法]使用随机平行对照单盲方法,将140例随机分为两组,对照组60例西药常规治疗,治疗组80例以祛风解表药为主治疗,西药治疗同对照组。10d为1疗程,治疗1疗程(10d)判定疗效。[结果]治疗组临床治愈27例,显效36例,有效14例,无效3例,总有效率96.25%。对照组临床治愈12例,显效15例,有效18例,无效15例,总有效率75.00%。治疗组总有效率、显效率均优于对照组(P<0.01)。[结论]以祛风解表药为主治疗缺血性中风急性期疗效满意,扩展了祛风解表药应用范围,开辟了治疗缺血性中风急性期新路径。
[Objective] To observe the curative effect of expelling wind and relieving epidermolysis drug combined with western medicine on acute ischemic stroke. [Methods] Randomized controlled single blind method was used to divide 140 patients into two groups randomly. The control group was treated routinely with 60 western medicine. The treatment group was treated mainly with Qufeng Decoction and the western medicine was the same as the control group. 10d for a course of treatment, treatment of 1 course of treatment (10d) to determine the efficacy. [Results] In the treatment group, 27 cases were clinically cured, 36 cases were markedly effective, 14 cases were effective, 3 cases were ineffective, and the total effective rate was 96.25%. In the control group, 12 cases were clinically cured, 15 cases were markedly effective, 18 cases were effective, 15 cases were ineffective, and the total effective rate was 75.00%. The total effective rate and effective rate in the treatment group were better than those in the control group (P <0.01). [Conclusion] The treatment of expelling wind and relieving epidermis is the main treatment of ischemic stroke in the acute phase of the satisfactory results, expanding the scope of the application of Qufeng relieving drugs, opened up a new path for the treatment of acute ischemic stroke.